Neogen Co. (NASDAQ:NEOG) Director James L. Herbert sold 41,000 shares of the company’s stock in a transaction dated Thursday, April 18th. The stock was sold at an average price of $56.09, for a total value of $2,299,690.00. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Shares of NASDAQ NEOG opened at $56.32 on Tuesday. Neogen Co. has a 1-year low of $50.60 and a 1-year high of $97.38. The stock has a market capitalization of $2.96 billion, a PE ratio of 46.55, a P/E/G ratio of 4.98 and a beta of 1.33.

Neogen (NASDAQ:NEOG) last issued its earnings results on Tuesday, March 26th. The company reported $0.25 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.27 by ($0.02). Neogen had a return on equity of 10.48% and a net margin of 14.96%. The company had revenue of $97.70 million during the quarter, compared to analysts’ expectations of $102.55 million. During the same period in the previous year, the company earned $0.32 EPS. Neogen’s quarterly revenue was up 3.0% on a year-over-year basis. As a group, research analysts expect that Neogen Co. will post 1.14 EPS for the current fiscal year.

Several hedge funds and other institutional investors have recently modified their holdings of NEOG. Norges Bank purchased a new stake in shares of Neogen in the fourth quarter worth about $49,259,000. WINTON GROUP Ltd boosted its position in shares of Neogen by 1,880.2% in the fourth quarter. WINTON GROUP Ltd now owns 194,379 shares of the company’s stock worth $11,080,000 after buying an additional 184,563 shares during the period. Ardevora Asset Management LLP boosted its position in shares of Neogen by 36.0% in the fourth quarter. Ardevora Asset Management LLP now owns 597,260 shares of the company’s stock worth $34,044,000 after buying an additional 158,100 shares during the period. Vanguard Group Inc. boosted its position in shares of Neogen by 3.1% in the third quarter. Vanguard Group Inc. now owns 5,020,145 shares of the company’s stock worth $359,091,000 after buying an additional 149,536 shares during the period. Finally, Vanguard Group Inc boosted its position in shares of Neogen by 3.1% in the third quarter. Vanguard Group Inc now owns 5,020,145 shares of the company’s stock worth $359,091,000 after buying an additional 149,536 shares during the period. 88.88% of the stock is owned by institutional investors.

NEOG has been the subject of several research analyst reports. BidaskClub upgraded Neogen from a “strong sell” rating to a “sell” rating in a research note on Wednesday, March 20th. ValuEngine lowered Neogen from a “buy” rating to a “hold” rating in a research note on Thursday, January 10th. Craig Hallum raised Neogen from a “hold” rating to a “buy” rating and set a $62.76 target price for the company in a research report on Tuesday, March 19th. Finally, Zacks Investment Research reaffirmed a “hold” rating on shares of Neogen in a research report on Monday, December 31st. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $62.76.

ILLEGAL ACTIVITY NOTICE: “Neogen Co. (NEOG) Director James L. Herbert Sells 41,000 Shares” was originally published by Marea Informative and is the sole property of of Marea Informative. If you are viewing this report on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The legal version of this report can be accessed at https://www.mareainformativa.com/news/2019/04/23/neogen-co-neog-director-james-l-herbert-sells-41000-shares.html.

About Neogen

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.

Featured Story: How Do You Make Money With Penny Stocks?

Insider Buying and Selling by Quarter for Neogen (NASDAQ:NEOG)

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.